Home|Journals|Articles by Year Follow on Twitter

Directory for Medical Articles
 

Open Access

Case Report

J App Pharm Sci. 2017; 7(1): 214-216


Penfluridol Induced Extrapyramidal symptoms (EPS): A Case Report

Sereen Rose Thomson, Balaji Ommurugan, Shalini Adiga, Navin Patil, Saurish Reddy.

Abstract
Penfluridol is a long acting oral antipsychotic agent taken once a week for the treatment of schizophrenia and other psychotic disorders. Weekly dosage regimen of the drug makes it an ideal drug in non-compliant patients, which is commonly seen in 50-75% of psychotic disorder patients. Better compliance may be associated with less relapses, better quality of life, less crises and less or shorter hospitalizations, leading to lower costs.
As a part of pharmacovigilance program of India, we hereby report a case of Penfluridol induced extrapyramidal symptoms in a patient with refractory schizophrenia who developed EPS even at the least possible dose of the drug. Relevant data was collected from case record as per Central Drug Standard Control Organisation form and causality, severity and preventability assessment was done as per Naranjo’s, Hartwigs and Schumock and Thornton scales respectively.

Key words: Typical antipsychotics, extrapyramidal symptoms, adverse drug reaction, refractory schizophrenia.



Similar Articles

Synthesis of enhanced corrosion resistant Fe-B-C-Ti amorphous ribbons and evaluation of their photodegradation efficiency under light irradiation.
Zuo M, Moztahida M, Lee DS, Yi S
Chemosphere. 2022; 287(Pt 2): 132175

Sensitive detection of trace 4-methylimidazole utilizing a derivatization reaction-based ratiometric surface-enhanced Raman scattering platform.
Gou L, Zeng X, Du H, Li L, Tian Y, Hou X, Wu L
Talanta. 2022; 237(): 122925

Hydrophobic and thermal-insulating aerogels based on rigid cellulose nanocrystal and elastic rubber.
Chen Z, Li Z, Lan P, Xu H, Lin N
Carbohydrate polymers. 2022; 275(): 118708

An environment-friendly dip-catalyst with xylan-based catalytic paper coatings.
He M, Song T, Qi H, Xiang Z
Carbohydrate polymers. 2022; 275(): 118707

Drug-drug interaction between cannabidiol and phenobarbital in healthy dogs.
Doran CE, McGrath S, Bartner LR, Thomas B, Cribb AE, Gustafson DL
American journal of veterinary research. 2022; (): 1-9


Full-text options


Latest Statistics about COVID-19
• pubstat.org


Add your Article(s) to Indexes
• citeindex.org






Covid-19 Trends and Statistics
ScopeMed.com
CiteIndex.org
CancerLine
FoodsLine
PhytoMedline
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright © ScopeMed® Information Services.



ScopeMed Web Sites